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Macroautophagy (hereafter referred to as autophagy) is a cellular pathway that delivers cytoplasmic proteins and organelles to the lysosome for degradation. It occurs at a basal level in nutrient-rich conditions but can be upregulated in response to various stress conditions, such as starvation. Autophagy can be non-selective (that is, a portion of the cytoplasm is engulfed, for example, in response to amino acid deprivation) or selective. Selective autophagy targets various cargoes for degradation; this includes organelle-specific autophagy (including mitophagy, pexophagy and reticulophagy) and xenophagy (which is the degradation of microorganisms)^[@CR1]^.

Autophagy has also emerged as an innate immune response pathway, targeting intracellular bacteria in the cytosol, in damaged vacuoles and in phagosomes to restrict bacterial growth. Autophagy can be induced on bacterial infection and involves the formation of double-membrane compartments (known as autophagosomes) around target bacteria and their transport to lysosomes for degradation^[@CR2]^. Extensive work has been done to determine the induction and targeting mechanisms of antibacterial autophagy. It is now thought that multiple host factors and pathways are activated and contribute to this process.

Increasing evidence also suggests that bacteria have evolved strategies to combat autophagy^[@CR3]^. Recent studies have indicated the existence of active interactions between bacterial factors and host autophagy components. Certain bacteria can inhibit the signalling pathways that lead to autophagy induction^[@CR4],[@CR5]^, mask themselves with host proteins to avoid autophagy recognition^[@CR6],[@CR7],[@CR8]^, interfere with the autophagy machinery to escape targeting^[@CR9],[@CR10]^ or block fusion of the autophagosome with the lysosome^[@CR11]^. Some bacteria even actively exploit autophagy components to promote their own intracellular growth^[@CR12],[@CR13]^. The mechanisms by which bacteria interfere with autophagy remain mostly unclear and are currently the subject of intense investigation.

In this Review, we provide an overview of the mechanisms of canonical and non-canonical autophagy and then focus on the interplay between bacteria and autophagy, including how autophagy targets bacteria for clearance and how bacteria block this process or hijack it for survival.

Mechanisms of autophagy {#Sec2}
=======================

The hallmark of autophagy is the formation of the double-membrane autophagosome, which captures and transports cytoplasmic components to the lysosome for degradation. In mammalian cells and yeast, autophagosomes are initiated at the phagophore assembly site (PAS)^[@CR14]^; an example of a PAS in mammals is the omegasome, a phosphatidylinositol 3-phosphate (PtdIns3P)-enriched subdomain of the endoplasmic reticulum (ER)^[@CR15]^. A group of autophagy-related (ATG) proteins are the key players in autophagy, although some also have non-autophagy functions ([Table 1](#Tab1){ref-type="table"}).Table 1Non-canonical functions of autophagy proteins[PowerPoint slide](#MOESM4){ref-type="media"}ATG proteinsFunctionDetailsRefsPtdIns3KC3, ATG14L and BECN1Phagosome--lysosome fusionInvolved in LAP, which promotes phagosome fusion with the lysosome[@CR69],[@CR71],[@CR144]PtdIns3KC3--PIK3R4--BECN1--UVRAGEndocytic membrane traffickingRegulation of endosome--lysosome fusion[@CR145]ATG14LEndocytic membrane traffickingEndosome maturation and lysosomal degradation of endocytosed cargoes by binding snapin[@CR146]ATG5ApoptosisAn amino-terminal fragment of ATG5 is cleaved by calpain and translocates to the mitochondria, causing cytochrome *c* release and caspase-dependent apoptosis[@CR147]Phagosome--lysosome fusionLAP and LC3 recruitment to entotic cell-containing vacuoles[@CR69],[@CR71],[@CR144]Cytokine productionIL-1β and IL-18 production by the non-classical secretory pathway[@CR148]Inhibition of antiviral immune responseATG5--ATG12 physically interacts with RIG-I, a viral RNA recognition helicase, and IPS1 to inhibit type I IFN production and promote viral replication[@CR149]Vacuole damage and GTPase recruitmentEssential for IFNγ-mediated clearance of *Toxoplasma gondii* by damaging the parasite-containing vacuole and targeting the IIGP1 to the vacuole[@CR150]Antigen presentationRequired for processing and presentation of TLR-engaged phagocytosed antigen[@CR151]ATG7Cytokine productionInvolved in LAP, which inhibits production of IL-1β and IL-6, but promotes production of IL-10 and TGFβ[@CR71]IFNα production upon DNA--IgG binding in plasmacytoid dendritic cells[@CR152]Cell cycle controlDirectly binds p53 and promotes p53-regulated transcription of cyclin-dependent kinase inhibitor p21^CDKN1A^ to control the cell cycle, but inhibits expression of p53-targeted pro-apoptotic genes to avoid cell death[@CR153]LC3Viral replicationDouble-stranded RNA coronaviruses and positive-strand RNA equine arteritis virus induce formation of LC3-I-coated double-membrane vesicles for viral replication[@CR133],[@CR154],[@CR155]Bacterial replication*Chlamydia trachomatis* forms non-infectious reticulate bodies, and LC3-I interacts with reticulate bodies and microtubules to promote bacterial replication[@CR156]Antigen presentationDectin 1-mediated ingestion of yeast triggers LAP, and LC3 is necessary for recruitment of MHC class II molecules to the phagosome and presentation of yeast antigens[@CR157]ATG, autophagy-related; ATG14L, ATG14-like; BECN1, beclin 1; IFN, interferon; IgG, immunoglobulin-γ; IIGP1, IFN-inducible GTPase 1; IL, interleukin; IPS1, IFNβ promoter stimulator 1; LAP, LC3-associated phagocytosis; LC3, microtubule-associated protein 1 light chain 3; LC3-I, non-lipidated LC3; MHC, major histocompatibility complex; PIK3R4, phosphoinositide 3-kinase regulatory subunit 4; PtdIns3KC3, phosphatidylinositol 3-kinase class III; RIG-I, retinoic acid-inducible gene 1; TGFβ, transforming growth factor-β; TLR, Toll-like receptor; UVRAG, UV radiation resistance-associated gene protein.

***Canonical and selective autophagy.*** Autophagy can be dissected into the following steps: signal induction, membrane nucleation, cargo targeting, vesicle expansion and autophagosome formation, fusion with the lysosome, cargo degradation and nutrient recycling^[@CR14]^ ([Fig. 1](#Fig1){ref-type="fig"}).Figure 1A diagram of the autophagy pathway.On stimulation of autophagy, a small membrane sac, known as the phagophore, is assembled and starts to elongate to enclose cytoplasmic components. The phagophore expands and grows into a double-membrane compartment, known as the autophagosome, which sequesters cytoplasmic targets, such as proteins, organelles and microorganisms. The autophagosome fuses with the lysosome to generate the autolysosome, in which the cargo is degraded by hydrolytic enzymes. Key proteins involved in autophagy in mammals are shown on the right. ATG, autophagy-related; ATG14L, ATG14-like; ATG16L1, ATG16-like 1; BECN1, beclin 1; FIP200, FAK family kinase-interacting protein of 200 kDa; LAMP2, lysosomal-associated membrane glycoprotein 2; LC3, microtubule-associated protein 1 light chain 3; PE, phosphatidylethanolamine; PIK3R4, phosphoinositide 3-kinase regulatory subunit 4; PtdInsKC3, phosphatidylinositol-3 kinase class III; ULK1, Unc-51-like kinase; VAMP8, vesicle-associated membrane protein 8; WIPI, WD-repeat domain phosphoinositide-interacting.[PowerPoint slide](#MOESM1){ref-type="media"}

Induction can be triggered by a range of signals, from nutrient limitation (in the case of non-selective autophagy) to the recognition of specific cargo, such as damaged mitochondria or bacteria^[@CR16]^. The Unc-51-like kinase 1 (ULK1; known as Atg1 in yeast) complex (which comprises ULK1, ATG13, FAK family kinase-interacting protein of 200 kDa (FIP200) and ATG101 (also known as C12orf44)) is the signal initiation complex and has a key role in recruiting ATG proteins to the PAS^[@CR17]^. In the presence of nutrients, the ULK1 complex is inhibited by mammalian target of rapamycin complex 1 (mTORC1; which promotes growth in nutrient-rich conditions)^[@CR17]^. mTORC1 phosphorylates ULK1 and ATG13, thus inhibiting the recruitment of the ULK1 complex to the PAS^[@CR18],[@CR19]^. By contrast, when mTORC1 is inactive (during nutrient limitation or rapamycin treatment), ULK1 is released^[@CR18],[@CR19]^, which enables it to phosphorylate FIP200, translocate to the PAS and recruit other ATG proteins to initiate autophagosome formation^[@CR18],[@CR19],[@CR20]^. The ULK1 complex is also essential for initiation during selective autophagy, although, in most cases, it is unclear whether ULK1 recruitment is regulated by mTORC1 or by other signalling molecules. For example, in yeast, Atg1 is required for pexophagy^[@CR21]^, mitophagy^[@CR22]^ and the [cytoplasm-to-vacuole targeting pathway](#Glos1){ref-type="list"} (Cvt pathway)^[@CR23]^, and in mammals FIP200 is crucial for the autophagic degradation of *Salmonella enterica* subsp. *enterica* serovar Typhimurium^[@CR24]^.

The ULK1 complex recruits beclin 1 (BECN1; Atg6 in yeast), ATG14-like (ATG14L) and phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4; vacuolar protein sorting-associated 15 (Vps15) in yeast) to the PAS, where they are involved in the phagophore membrane nucleation step. This is achieved by engaging PtdIns3-kinase class III (PtdIns3KC3; Vps34 in yeast), resulting in the production of PtdIns3P at the phagophore. This leads to the recruitment of PtdIns3P-binding proteins, such as WD-repeat domain phosphoinositide-interacting 1 (WIPI1; Atg18 in yeast) and WIPI2 (Atg21 in yeast) to the PAS to aid phagophore assembly by, at least in yeast, recruiting downstream Atg proteins (Atg16 and Atg8; see below)^[@CR25],[@CR26]^. ATG9 is also important for phagophore assembly. In yeast, Atg9 exits from the [*trans*-Golgi network](#Glos2){ref-type="list"} (TGN) and associates with small vesicles^[@CR27],[@CR28]^, some of which contribute membranes, at least partially, for phagophore biogenesis^[@CR27],[@CR28]^. In mammals, ATG9 localizes at the TGN and on endosomes, transiently interacts with omegasomes and is required for PAS formation and expansion^[@CR29],[@CR30]^. However, ATG9 is not incorporated into the PAS.

Autophagosome elongation is mediated by two ubiquitin-like conjugation systems. The ATG12--ATG5 ubiquitin-like-conjugate, which is activated by the [E1-like enzyme](#Glos3){ref-type="list"} ATG7 and the [E2-like enzyme](#Glos4){ref-type="list"} ATG10, promotes phagophore elongation^[@CR31],[@CR32]^. In addition, ATG12--ATG5 forms a complex with ATG16L1, which associates with the expanding phagophore membrane^[@CR33]^ but is released from the autophagosome membrane when the vesicle is complete^[@CR32]^. The fusion of ATG16L1- associated precursor vesicles with each other is mediated by [SNARE proteins](#Glos5){ref-type="list"} and possibly contributes to the phagophore expansion process^[@CR34]^. ATG12--ATG5 is necessary for the formation of the second ubiquitin-like conjugate, light chain 3 (LC3; also known as MAP1LC3B; Atg8 in yeast)--phosphatidylethanolamine (PE), which is activated by the E1-like enzyme ATG7 and the E2-like enzyme ATG3. The ATG12--ATG5--ATG16L1 complex directs LC3 to the target membrane^[@CR35]^, where it becomes conjugated to PE by the [E3-like enzyme](#Glos6){ref-type="list"} activity of ATG12--ATG5 (Ref. [@CR36]). The cysteine protease ATG4B is also required for LC3--PE formation, as it cleaves the carboxyl terminus of LC3 and exposes a glycine residue that is then covalently attached to PE^[@CR37]^. In addition, ATG4B deconjugates a proportion of the LC3--PE complexes when autophagosome formation is complete, thus facilitating the recycling of LC3 for the formation of new autophagosomes^[@CR37],[@CR38]^. Recent studies in yeast indicate that this deconjugation process is necessary for efficient autophagosome biogenesis as well as for maturation of the autophagosome into a fusion-capable autophagosome^[@CR38],[@CR39]^. LC3 has been shown to mediate the hemifusion of vesicles and to control the size of the autophagosome in yeast^[@CR40],[@CR41]^.

Eventually, autophagosomes mature into degradative autolysosomes by a series of fusion events with endosomes and lysosomes. In mammals, the fusion of an autophagosome with a lysosome requires the small GTPase RAB7 (Ypt7 in yeast)^[@CR42]^, the autophagosomal SNARE protein syntaxin 17 (Ref. [@CR43]) and the lysosomal SNARE vesicle-associated membrane protein 8 (VAMP8), as well as lysosomal membrane proteins, such as lysosomal-associated membrane glycoprotein 2 (LAMP2)^[@CR44],[@CR45]^. In yeast, the vesicle SNARE (v-SNARE) proteins vacuolar morphogenesis protein 7 (Vam7) and Ykt6, the target SNARE (t-SNARE) proteins Vam3 and Vti1, the GTPase Ypt7, the Ypt7 [guanine nucleotide exchange factor](#Glos7){ref-type="list"} (GEF) monensin sensitivity 1--calcium-caffeine-zinc sensitivity 1 (Mon1--Ccz1) and homotypic vacuole fusion and vacuole protein sorting (HOPS) proteins^[@CR46]^ are all required for autophagosome fusion with the vacuole (which is the yeast counterpart of the lysosome). Lysosomal breakdown of the inner autophagosomal membrane and the autophagosome cargo is mediated by lysosomal hydrolases.

Selective autophagy has an additional step --- cargo selection --- which is mediated by cargo receptors and adaptor proteins. In mammalian cells, cargo-specific receptors usually contain an LC3-interacting region (LIR) that mediates the recruitment of LC3-decorated autophagosomes to the cargo (for example, mitochondria)^[@CR47],[@CR48],[@CR49]^. Moreover, ubiquitin-associated cargoes are recognized by ubiquitin-binding protein adaptors, which also contain LIRs^[@CR50]^. One example is p62, which links various cargo targets, including ubiquitylated protein aggregates^[@CR51],[@CR52]^, ubiquitin-tagged peroxisomes^[@CR53]^ and bacteria^[@CR8],[@CR54],[@CR55]^, to autophagosomes. Other adaptor proteins that have both a ubiquitin-binding domain and an LIR have also been discovered, including NBR1 (next to BRCA1 gene 1)^[@CR56]^, NDP52 (nuclear dot protein 52 kDa; also known as CALCOCO2)^[@CR57]^ and optineurin^[@CR58]^. NBR1 is involved in the targeting of protein aggregates^[@CR56]^, peroxisomes^[@CR59]^ and the bacterial pathogen *Francisella tularensis*^[@CR60]^ for autophagy; NDP52 and optineurin, together with p62, are involved in the autophagy of *S*. Typhimurium^[@CR55],[@CR57],[@CR58]^.

***Alternative (non-canonical) autophagy.*** Recent studies have identified alternative autophagy pathways that are independent of some of the core machinery components; these are known as non-canonical forms of autophagy. For example, autophagy that is independent of ULK1 and ULK2 has been observed after long-term glucose starvation^[@CR61]^. Moreover, a recent study found that autophagy can occur in *Atg5*-knockout mouse embryonic fibroblasts^[@CR62]^. ATG5-independent autophagy, which contributes to organelle clearance during erythrocyte maturation, depends on the ULK1 complex and BECN1 but does not require LC3--PE and several other essential conventional autophagy components, including ATG7, ATG12, ATG16L1 and ATG9. BECN1-independent autophagy has also been identified in cancer cell lines, in which it is induced by apoptotic stimuli, such as staurosporine^[@CR63]^, and by the antioxidant resveratrol^[@CR64]^, as well as in non-tumour cell lines, in which it is induced by the neurotoxin 1-methyl-4-phenylpyridinium^[@CR65]^ and by the recombinant viral capsid protein VP1 of foot-and-mouth disease virus^[@CR66]^, among others. BECN1-independent autophagy involves the formation of double-membrane autophagosomes and requires the ULK1 complex, ATG5, ATG7 and LC3--PE conjugation systems, but the exact mechanism remains unclear^[@CR63],[@CR64],[@CR67]^.

A recent study identified a non-canonical form of autophagy in which the autophagosome was derived from the late endosome --- a process known as endosome-mediated autophagy (ENMA)^[@CR68]^. ENMA is induced by the [Toll-like receptor](#Glos8){ref-type="list"} (TLR) ligand lipopolysaccharide in [dendritic cells](#Glos9){ref-type="list"}, which contain late endosomes known as major histocompatibility complex (MHC) class II-containing compartments (MIICs). Typical MIIC marker proteins and autophagy proteins, including LC3 and ATG16L1, were associated with these MIIC-derived autophagosomes. Notably, ENMA was independent of ATG4B and LC3 conjugation to PE, as the MIIC-derived autophagosomes were formed in *Atg4b*-knockout dendritic cells.

During TLR- or [Fc receptor](#Glos10){ref-type="list"}-mediated phagocytosis in professional phagocytic cells, autophagy components, including LC3, BECN1, PtdIns3KC3 and ATG12--ATG5, are translocated to the phagosomal membrane to promote phagosome fusion with the lysosome^[@CR69],[@CR70]^. This process does not involve the formation of a double- membrane autophagosome and has been termed LC3-associated phagocytosis (LAP). Induction of LAP is independent of the ULK1 complex^[@CR71]^ but requires the activity of NADPH oxidase and the production of [reactive oxygen species](#Glos11){ref-type="list"} (ROS)^[@CR70]^. NADPH oxidase is activated and assembled on the phagosomal membrane during the phagocytosis of microorganisms and generates ROS in the phagosomal lumen to directly kill them. How ROS induce the recruitment of LC3 to the phagosome, and how autophagy components facilitate lysosomal fusion, remains unknown. Notably, LAP is thought to restrict the growth of bacterial pathogens, such as *S*. Typhimurium^[@CR70]^ and *Burkholderia pseudomallei*^[@CR72]^, in host cells.

Autophagy as an antibacterial defence {#Sec3}
=====================================

As mentioned above, bacteria have been identified as targets of selective autophagy, and this process is known as xenophagy. In this context, autophagy acts as an innate immune mechanism against bacterial infection. Autophagy can target intracellular bacteria either in the cytosol or in vacuoles to restrict their growth ([Fig. 2a](#Fig2){ref-type="fig"}). In most cases, LC3-decorated autophagosomes are formed around the target bacteria^[@CR2]^ and deliver them into the lysosome for degradation.Figure 2Autophagy is an antibacterial mechanism.**a** \| Schematic diagram of the ways that autophagy targets intracellular bacteria. After invasion of host cells, the bacterium resides in a bacterium-containing vacuole (or phagosome). Some bacteria damage the vacuolar or phagosomal membrane and eventually escape into the cytosol. Autophagy can target bacteria in damaged vacuoles or phagosomes (as with, for example, *Mycobacterium tuberculosis* and *Salmonella enterica* subsp. *enterica* serovar Typhimurium) or in the cytosol (as with, for example, Group A *Streptococcus*) and deliver them to the lysosome for degradation. **b** \| Model of the antibacterial autophagy of *S*. Typhimurium. The bacterium resides in a *Salmonella*-containing vacuole (SCV) after invading epithelial cells. Early after infection (∼1 hour), the membrane of a subset of SCVs is damaged and the bacterium is exposed to the cytoplasm, where it becomes associated with ubiquitylated proteins in a process that depends on the E3 ubiquitin ligase leucine-rich repeat and sterile α-motif-containing 1 (LRSAM1). Next, adaptor proteins, including p62, NDP52 (nuclear dot protein 52 kDa) and optineurin (OPTN) are recruited to the SCV by binding to ubiquitin, and they recruit autophagosomes by interacting with microtubule-associated protein 1 light chain 3 (LC3), ultimately resulting in autolysosome formation. The damaged SCV membrane also exposes β-glycans to the cytoplasm and recruits galectin 8 (GAL8), which binds to NDP52 and further recruits LC3. Also at ∼1 hour post-infection, a subset of bacteria recruits diacylglycerol (DAG) to the undamaged SCVs. DAG activates protein kinase Cδ (PKCδ), which activates NADPH oxidase (NOX) and promotes reactive oxygen species (ROS) production, in turn inducing LC3-associated phagocytosis of bacteria. At ∼4 hours post-infection, mammalian target of rapamycin (mTOR) is redistributed to the SCV membrane, which inhibits autophagy induction, resulting in autophagy escape and enabling bacteria to replicate in SCVs. T3SS, type III secretion system.[PowerPoint slide](#MOESM2){ref-type="media"}

***Autophagy targeting*** **S.** ***Typhimurium.*** One well-studied example of a bacterium that is targeted for autophagy is *S*. Typhimurium ([Fig. 2b](#Fig2){ref-type="fig"}). Autophagy is essential for restricting the growth of this bacterium in *Caenorhabditis elegans* and *Dictyostelium discoideum*^[@CR73]^. *S*. Typhimurium uses its two type III secretion systems (T3SSs; encoded by *Salmonella* pathogenicity island 1 (SPI-1) and SPI-2) to invade epithelial cells, and typically resides in the *Salmonella*-containing vacuole (SCV)^[@CR74]^. However, a subset of bacteria damages the SCV membrane early after infection, via SPI-1 T3SS pore-forming activities on the vacuolar membrane, and can potentially escape into the cytosol to obtain nutrients for rapid growth^[@CR75]^. Some of the cytosol-exposed bacteria are targeted by autophagy within damaged SCVs, as shown by the recruitment of LC3 and other ATG proteins to the bacteria. As a consequence, autophagy protects the cytosol from bacterial colonization^[@CR76]^.

How *S*. Typhimurium is selectively targeted to autophagosomes has been the subject of many studies. Evidence suggests that SCV membrane damage exposes specific signature molecules either on the bacterial surface or on the inner face of the SCV membrane, and in turn, these molecules recruit adaptor proteins from the cytosol that then recruit autophagy components to the SCV ([Fig. 2b](#Fig2){ref-type="fig"}). For example, it has been shown that a population of bacteria is associated with ubiquitylated proteins shortly after invasion, indicating exposure to the cytosol^[@CR76]^. These ubiquitin-positive bacteria also colocalize with adaptor protein p62 (see above) and LC3 (Ref. [@CR55]), which suggests that p62 links the bacteria to autophagosomes via LC3. The adaptor protein optineurin^[@CR58]^ also has a role in bacterial autophagy: phosphorylation of optineurin by the innate immune receptor TANK-binding kinase 1 (TBK1; which activates the transcription of [type I interferons](#Glos12){ref-type="list"} (IFNs)) strengthens its interaction with LC3, which restricts the intracellular growth of *S*. Typhimurium^[@CR58]^. Recently, a host ubiquitin E3 ligase, leucine-rich repeat and sterile α-motif-containing 1 (LRSAM1), was found to have a role in the ubiquitylation of proteins that are associated with the autophagy of *S*. Typhimurium^[@CR77]^, but the ubiquitylated host and bacterial proteins that are involved are unknown.

Other host molecules are also thought to participate in the autophagic targeting of bacteria and to interact with autophagy adaptor proteins. Specifically, SCV membrane damage exposes the host cell sugar molecule β-galactoside --- which normally localizes to the plasma membrane surface and luminal face of endosomes, including SCV membranes --- to the cytosol. This β-galactoside is recognized by its cytosolic receptor, galectin 8, which binds NDP52 and thus recruits LC3 to the damaged SCV^[@CR78]^. Remarkably, it is the recruitment of NDP52 to bacteria through galectin 8 binding, not ubiquitin binding, that is required for NDP52-mediated autophagy of *S*. Typhimurium.

Therefore, both ubiquitin and sugar signals contribute to the autophagy of bacteria in damaged vacuoles. The existence of three adaptor-mediated pathways (p62, optineurin and NDP52) might guarantee the maximal targeting of cytosol-exposed bacteria, although the order of activation of each pathway is not entirely clear at the moment. The peak of LC3 association with *S*. Typhimurium is at 1 hour post-infection, a time at which both ubiquitin and galectin 8 have been recruited to the bacteria^[@CR76],[@CR78]^. It is possible that ubiquitin recruits p62 and optineurin to the bacteria at the same time and that galectin 8 recruits NDP52 in parallel. More precise kinetic and microscopic studies are needed to resolve the order of translocation of ubiquitin and galectin 8 to the bacteria at the early stages of infection.

Other core machinery autophagy components, such as ULK1, FIP200, ATG14L, ATG16L1 and ATG9, are also targeted to the SCV, and each of them has a role in restricting the intracellular growth of *S*. Typhimurium^[@CR24]^. However, targeting of LC3 to the SCV is independent of the essential autophagy factors (the ULK1 complex, the BECN1 complex and ATG9). Therefore, LC3 can be recruited to SCVs by at least one other, non-canonical pathway. Indeed, *S*. Typhimurium is also targeted by the LAP pathway. It has been shown that NADPH oxidase and ROS are necessary for efficient recruitment of LC3 to bacteria^[@CR70]^. In addition, the lipid signalling molecule diacylglycerol (DAG) is recruited to SCVs, and its production is necessary for efficient LC3 recruitment to bacteria^[@CR79]^. In fact, DAG-positive bacteria are not associated with ubiquitin or p62, and inhibiting both DAG and p62 leads to an additive inhibitory effect on LC3 recruitment to the bacteria. These results suggest that the DAG pathway and the ubiquitin-adaptor pathway contribute independently to the recruitment of LC3 to *S*. Typhimurium. The downstream effector of DAG, protein kinase Cδ (PKCδ), is also required for LC3 recruitment to bacteria^[@CR79]^. PKCδ can activate NADPH oxidase by phosphorylation of one of its components^[@CR80]^, which suggests that DAG-dependent LC3 targeting of bacteria involves the PKCδ--NADPH oxidase--ROS pathway. It remains unknown what triggers the translocation of DAG to the SCVs. The SPI-1 T3SS of *S*. Typhimurium is required for DAG localization on the SCVs, suggesting that either bacterial effectors or the membrane damage caused by T3SS pore-forming activity is involved. Whether LAP occurs before canonical autophagy targets *S*. Typhimurium is not clear. ROS production is very rapid after bacterial invasion (peaking at ∼10 min post-infection)^[@CR81]^, and association of DAG with *S*. Typhimurium peaks at 30 min post-infection^[@CR79]^. It has also been suggested that ROS might contribute to damaging SCV membranes. Therefore, activation of LAP signalling might occur slightly earlier than activation of the ubiquitin--adaptor--autophagy pathway. Correlative electron microscopy studies are needed to distinguish LAP from the canonical autophagy pathway.

***Other bacteria targeted by autophagy.*** *Mycobacterium tuberculosis* is another example of a bacterium that is targeted for autophagy in damaged vacuoles ([Fig. 2a](#Fig2){ref-type="fig"}). During infection of macrophages, *M. tuberculosis* blocks phagosome maturation and replicates in the phagosome. A recent study showed that ∼30% of phagosomal mycobacteria were selectively targeted by LC3 and ATG12 by 4 hours post-infection^[@CR82]^. The membrane-permeabilization factor early secreted antigenic target of 6 kDa (ESAT-6; also known as EsxA), which is the major substrate secreted from the bacterial type VII secretion system ESX-1, is required for the targeting of *M. tuberculosis* for autophagy. Autophagy is thought to be triggered following damage to the *M. tuberculosis*-containing phagosomes, with ubiquitylation of host and bacterial proteins having a major role. Ubiquitin-associated bacteria colocalize with p62, NDP52 and LC3, which suggests that phagosomal damage triggers bacterial targeting by LC3 and adaptor proteins, and thus allows targeting of the bacteria by selective autophagy^[@CR82]^. The same study found that naked bacterial DNA in the host cytosol can function as the signal that triggers autophagy, possibly through the activation of TBK1 and [STING](#Glos13){ref-type="list"}, both of which are necessary for ubiquitin-mediated selective autophagy of *M. tuberculosis*^[@CR83]^. The ubiquitin E3 ligase Parkin was recently implicated in autophagy of these bacteria^[@CR84]^.

Autophagy also selectively targets cytosolic bacteria, such as Group A *Streptococcus* (GAS)^[@CR85]^. When actively invading HeLa cells, GAS escapes from the endosomes to the cytoplasm, in a process that is mediated by the toxin streptolysin O (SLO), a member of a family of cholesterol-dependent pore-forming cytolysins^[@CR86]^. Most cytosolic bacteria are enveloped in LC3-decorated, GAS-containing autophagosome-like vacuoles (GcAVs) and are degraded through autophagy^[@CR85]^ ([Fig. 2a](#Fig2){ref-type="fig"}). GcAV formation and bacterial clearance are severely impaired in *Atg5*-knockout mouse embryonic fibroblasts compared with wild-type cells, in which most bacteria are killed during the first 4 hours post-infection. Moreover, SLO is necessary for autophagic targeting of the bacteria, as SLO-deficient mutants are not sequestered in LC3-positive autophagic structures and survive longer than wild-type bacteria^[@CR85],[@CR86]^. Notably, SLO-deficient mutants remain in endosomes and cannot escape to the cytosol of HeLa cells, so bacterial exposure to the cytosol may function as the signal for antibacterial autophagy. Engagement of the human cell surface pathogen receptor CD46 has also been shown to induce autophagy clearance of GAS by activating BECN1 and PtdIns3KC3 (Ref. [@CR87]).

In addition to ATG proteins, members of the RAB GTPase family localize to GcAVs and are involved in their formation. For example, RAB7, which mediates late endosome maturation, and RAB23, which regulates intracellular vesicle transport, were found to be necessary for the formation of GcAVs^[@CR86],[@CR88]^. RAB9A, which mediates protein transport from late endosomes to the TGN, is required for GcAV enlargement and fusion with the lysosomes^[@CR88]^. RAB9A and RAB23 are not involved in starvation-induced canonical autophagosome formation^[@CR88]^, which suggests that they have unique roles in selective bacterial autophagy.

Another study showed that, in human oropharyngeal keratinocytes, GAS uses both SLO (which is required for the association with ubiquitin) and the pore-forming cytolysin streptolysin S (SLS; which is required for the association with galectin 8) to damage the vacuolar membrane, resulting in its association with ubiquitin or galectin 8 and consequent targeting by autophagy adaptor proteins^[@CR89]^. However, in this study, SLO was shown to promote bacterial survival in human oropharyngeal keratinocytes. Together with NAD glycohydrolase, a toxin that is encoded in the same operon, SLO inhibits the fusion of GcAVs with lysosomes^[@CR89]^. Thus, in human oropharyngeal keratinocytes, GAS infection induces the xenophagic response, but bacterial toxins inhibit the formation of mature autolysosomes and enable bacterial survival. This is a more complex interaction between bacteria and autophagy than that seen in HeLa cells, in which autophagy kills most bacteria during early infection^[@CR85]^.

Manipulating autophagy {#Sec4}
======================

Although some bacteria are targeted and eliminated by autophagy, others have developed ways to escape this defence system or even hijack the autophagy machinery to promote their intracellular growth ([Fig. 3](#Fig3){ref-type="fig"}; [Table 2](#Tab2){ref-type="table"}). In addition to the examples that are discussed below, other bacteria, such as *F. tularensis*, *Yersinia enterocolitica* and *Orientia tsutsugamushi* have been reported to escape autophagy, but the bacterial and host factors that are involved have not been fully elucidated^[@CR60],[@CR90],[@CR91],[@CR92],[@CR93]^.Figure 3Bacteria manipulate autophagy for survival.**a** \| A diagram of how bacteria interfere with the autophagy machinery. Bacteria actively invade mammalian cells and secrete effectors to modulate the host cell machinery. Some bacteria use their effectors or toxins to interfere with the autophagy machinery at various stages in order to escape autophagic killing. Methods include inhibiting the autophagy induction signal (as with Eis (enhanced intracellular survival) from *Mycobacterium tuberculosis*, oedema factor toxin from *Bacillus anthracis* and cholera toxin from *Vibrio cholerae*), inhibiting recognition by the autophagy machinery (as with IcsB from *Shigella flexneri*, and ActA and internalin K (InlK) from *Listeria monocytogenes*), directly interfering with autophagy components (as with RavZ from *Legionella pneumophila* and VirA from *S . flexneri*) or blocking autophagosome fusion with the lysosome (as with ESAT-6 (early secreted antigenic target of 6 kDa) from *M . tuberculosis* and VacA from *Helicobacter pylori*). **b** \| Model of *S*. *flexneri* evasion of autophagy. Wild-type bacteria escape the phagosomal compartment into the cytosol, where they recruit actin tails and replicate. The secreted effector IcsB binds to the bacterial surface protein VirG to block autophagy-related 5 (ATG5). IcsB also prevents formation of septin cages around the bacteria. The effector protein VirA inactivates RAB1 GTPase through its GTPase-activating protein (GAP) activity and inhibits autophagy. Δ*icsB*-mutant bacteria are recognized by nucleotide-binding oligomerization domain-containing 1 (NOD1) and NOD2, which interact with ATG16-like 1 (ATG16L1) and recruit autophagosomes to the invaded bacteria. In addition, ATG5 binds VirG and targets bacteria to autophagosomes. T3SS, type 3 secretion system.[PowerPoint slide](#MOESM3){ref-type="media"}Table 2Factors involved in the bacterium--autophagy interplay[PowerPoint slide](#MOESM5){ref-type="media"}BacteriumBacterial factorsHost factorsRefs***Inhibiting autophagy initiation signalling****S*. TyphimuriumUnknownmTOR, RAG GTPases and Ragulator[@CR5]*Mycobacterium tuberculosis* str. H37RvEisJNK and ROS[@CR95],[@CR96]*Bacillus anthracis*Oedema factor toxincAMP[@CR4]*Vibrio cholerae*Cholera toxincAMP[@CR4]***Directly interfering with the activity of autophagy components****Legionella pneumophila*T4SS effector RavZ and other unknown factorsLC3--PE[@CR10]*Shigella flexneri*VirARAB1[@CR9]***Evading autophagy recognition by masking the bacterial surface****S. flexneri*IcsBATG5 and septins[@CR6],[@CR54],[@CR108]*Listeria monocytogenes*ActA and InlKMVP and host factors that bind ActA[@CR7],[@CR8],[@CR111],[@CR113],[@CR158]***Escaping autophagy by yet unclear mechanisms****Burkholderia pseudomallei*T3SS3 effector BopA and translocator BipD, T3SS1 ATPase encoded by *bpscN*Unknown[@CR72],[@CR114]*Francisella tularensis*DipAUnknown[@CR60],[@CR90]*M. tuberculosis* str. ErdmanUnknownCoronin 1a[@CR117]*Yersinia enterocolitica*T3SSUnknown[@CR91]*Orientia tsutsugamushi*UnknownUnknown[@CR92],[@CR93]***Blocking autophagosome fusion with the lysosome***Adherent-invasive *Escherichia coli*UnknownUnknown[@CR11]*Mycobacterium marinum*ESX-1 secretion systemUnknown[@CR119]*M. tuberculosis* str. H37RvESAT-6 secreted from ESX-1 systemUnknown[@CR120]*Chlamydia trachomatis*UnknownUnknown[@CR121],[@CR122]*Helicobacter pylori*VacAUnknown[@CR124]*Yersinia pestis*UnknownUnknown[@CR123]***Hijacking autophagy for bacterial replication****Staphylococcus aureus*Hla secreted by the Agr systemcAMP, EPAC, RAP2B and calcium[@CR13],[@CR139],[@CR140]*Anaplasma phagocytophilum*Anaplasma translocated substrate 1 secreted by T4SSLC3, BECN1 and ATG14L[@CR12],[@CR126]*Coxiella burnetii*UnknownLC3, BECN1, RAB24 and BCL-2[@CR127],[@CR128],[@CR129],[@CR130]*Brucella abortus*UnknownULK1, BECN1, ATG14L and PtdIns3KC3[@CR131]*L. pneumophila*T4SSCholesterol[@CR134]*M. tuberculosis* str. ErdmanUnknownUnknown[@CR133]*Brucella melitensis*UnknownUnknown[@CR135]*C. trachomatis*UnknownLC3-I[@CR156]*Porphyromonas gingivalis*UnknownUnknown[@CR136]Uropathogenic *E. coli*UnknownATG16L1[@CR137]*Yersinia pseudotuberculosis*Bacterial protein synthesisUnknown[@CR138]*Serratia marcescens*UnknownUnknown[@CR132]Agr, accessory gene regulator; ATG, autophagy-related; ATG14L, ATG14-like; ATG16L1, ATG16-like 1; BCL-2, B cell lymphoma 2; BECN1, beclin 1; cAMP, cyclic AMP; Eis, enhanced intracellular survival; EPAC, exchange protein directly activated by cAMP 1; ESAT-6, early secreted antigenic target of 6 kDa; Hla, α-haemolysin; JNK, JUN N-terminal kinase; LC3, microtubule-associated protein 1 light chain 3; LC3-I, non-lipidated LC3; mTOR, mammalian target of rapamycin; MVP, major vault protein; PE, phosphatidylethanolamine; PtdIns3KC3, PtdIns 3-kinase class III; ROS, reactive oxygen species; *S*. Typhimurium, *Salmonella enterica* subsp. *enterica* serovar Typhimurium; T3SS, type III secretion system; T4SS, type IV secretion system; ULK1, Unc-51-like kinase 1.

***Inhibition of autophagy-initiation signalling.*** Some bacteria have developed strategies to inhibit the signalling cascade that initiates autophagy. For example, it has been shown that, early after *S*. Typhimurium infection (1 hour post-infection), membrane damage triggers a transient cytosolic amino acid starvation response, as shown by the activation of the amino acid sensor GCN2 (a kinase that phosphorylates the translation initiation factor eukaryotic initiation factor-2α (eIF2α), which controls protein synthesis)^[@CR5]^. This acute amino acid starvation inhibits mTORC1 activity and relocalizes mTOR (which is a part of mTORC1) from the late endosome to the cytosol^[@CR5]^, thus activating autophagy signalling. However, by 4 hours post-infection, the cytosolic amino acid pool is restored and mTOR is reactivated; mTOR then relocalizes to late endosomes and SCVs, thus inhibiting autophagy targeting towards *S*. Typhimurium ([Fig. 2b](#Fig2){ref-type="fig"}). Interestingly, inactivation of mTORC1 by rapamycin treatment resulted in an association of ∼50% of bacteria with LC3 at 4 hours post-infection, which suggests that *S*. Typhimurium escapes autophagy targeting at this time point by promoting mTORC1 activation. Although it remains unclear how this is achieved, it has been shown that SPI-2 T3SS is upregulated 4 hours after infection^[@CR94]^, and SPI-2 T3SS, or its secreted effectors, might have a role in the relocalization of mTORC1 regulators to the SCVs.

Another example of a bacterium that has evolved to avoid autophagy is *M. tuberculosis* str. H37Rv. In this bacterial strain, deletion of the gene encoding Eis (enhanced intracellular survival) induces the formation of autophagosomes following the infection of bone marrow-derived macrophages, which suggests that Eis can inhibit autophagy activation during infection by wild-type bacteria^[@CR95]^. Further analysis revealed that this is achieved by interfering with JUN N-terminal kinase (JNK) signalling, thus blocking the production of ROS (which are required for autophagy triggering): Eis-mutant bacteria were found to activate JNK and to consequently promote the production of ROS^[@CR95]^. Eis is an *N*-acetyltransferase that acetylates and activates a JNK-specific phosphatase, mitogen-activated protein kinase phosphatase 7, which inhibits JNK phosphorylation and leads to its inactivation^[@CR96]^.

In addition, bacterial toxins have been shown to inhibit autophagy induction by modulating the levels of cyclic AMP, a second messenger that regulates many cellular processes, such as lipid and glucose metabolism and pro-inflammatory cytokine production^[@CR97],[@CR98]^. cAMP is thought to negatively regulate autophagy, as its major effector, protein kinase A (PKA)^[@CR97]^, inhibits autophagy in yeast by directly phosphorylating Atg13 (which is a component of the Atg1 complex), and cAMP- and PKA-modulating drugs have been reported to block autophagy in mammals^[@CR99]^. Many bacteria express cAMP-increasing toxins to inhibit host innate immune responses. For example, oedema factor toxin from *Bacillus anthracis* is an adenylyl cyclase that can directly increase intracellular cAMP levels^[@CR100]^, and cholera toxin from *Vibrio cholerae* is an ADP ribosyltransferase that is capable of indirectly increasing cAMP by activating host adenylyl cyclases^[@CR101]^. Both toxins have inhibitory effects on host cell autophagy induction: when cells were treated with purified toxins, the induction of different types of autophagy was significantly reduced, including rapamycin-induced autophagy, *S*. Typhimurium-induced autophagy and LAP^[@CR4]^, suggesting that cAMP regulates an upstream signal that is common for all of the above tested autophagy pathways.

***Direct interference with the activity of autophagy components.*** Some bacteria inhibit autophagy by directly interfering with the activity of autophagy components ([Fig. 3a](#Fig3){ref-type="fig"}). For example, *Legionella pneumophila* induces autophagy in infected mouse macrophages in a manner that is dependent on the bacterial type IV secretion system (T4SS; known as the Dot/Icm secretion system)^[@CR102]^. The bacterium is internalized in a phagosome wrapped by ER structures (a process that is thought to favour bacterial growth), in which autophagy components, such as ATG7 and LC3, are sequentially recruited to eventually deliver the bacterium to lysosomes^[@CR102]^. However, it was recently shown that *L. pneumophila* can avoid autophagy targeting during infection of human embryonic kidney 293 cells^[@CR10]^ by the production of the T4SS effector RavZ. This protein functions as an ATG4B-like cysteine protease that directly targets the amide bond between the tyrosine and the glycine at the C terminus of LC3, which is covalently linked to PE on autophagy induction to form LC3--PE^[@CR10]^. Therefore, RavZ irreversibly deconjugates LC3 from PE and inhibits autophagosome formation. This is the first evidence of a bacterial effector protein mimicking the function of a host autophagy component to modify another critical autophagy protein and inhibit the whole process.

Another example of a bacterium that interferes with autophagy components is *Shigella flexneri*, which invades epithelial cells and escapes from the endosomal compartment into the cytoplasm to multiply and disseminate to other cells. *S. flexneri* can evade autophagy by directly inactivating the autophagy regulator RAB1, which is a small RAB GTPase that also mediates ER-to-Golgi trafficking. Recent studies have shown that RAB1 is required for autophagosome formation in mammalian cells^[@CR103],[@CR104]^, possibly by controlling the levels of PtdIns3P on the omegasome by targeting the PtdIns3-phosphatase myotubularin-related 6 to the omegasomal membrane^[@CR105]^. Another study reported that the *S. flexneri* T3SS effector VirA has a GTPase-activating protein (GAP) domain, which suggests that it can inactivate RAB GTPases^[@CR9]^. Indeed, in wild-type bacteria, VirA inactivates RAB1, thus inhibiting autophagy induction and, in the absence of VirA, bacteria are more efficiently decorated by LC3 (Ref. [@CR9]) ([Fig. 3b](#Fig3){ref-type="fig"}).

***Evasion of autophagy recognition by masking the bacterial surface.*** Some bacteria avoid recognition by the autophagy machinery by masking themselves with host molecules. One such example is *S. flexneri*, which produces IcsB, a virulence factor secreted by the T3SS that is important for bacterial pathogenesis at a post-invasion stage^[@CR106],[@CR107]^. Δ*icsB* bacteria, which still escape into the cytosol, have a reduced ability to spread into neighbouring cells in certain polarized cells^[@CR106],[@CR107]^. These bacteria become sequestered in multilamellar autophagosomes by the ubiquitin--p62 and NDP52--LC3 pathways, and show defective replication^[@CR6],[@CR54]^. Compared with Δ*icsB* bacteria (of which ∼35% are targeted to autophagosomes at 2 hours post-infection and ∼50% are targeted to autophagosomes at 6 hours post-infection), only ∼10% of wild-type bacteria are targeted for autophagy throughout the first 6 hours of infection, which suggests that *S. flexneri* uses IcsB to escape autophagy^[@CR6]^. In fact, IcsB binds to a bacterial surface protein, IcsA (also known as VirG), and competes with its binding to host ATG5, thereby masking the bacteria from ATG protein recognition^[@CR6]^ ([Fig. 3b](#Fig3){ref-type="fig"}). In addition, when compared with wild-type bacteria, Δ*icsB* mutants are more frequently surrounded by cage-like structures formed by septins, a group of conserved GTP-binding proteins that are often found at the cell-bud neck during cell division, and these entrapped bacteria are targeted for autophagy^[@CR108]^. As septins are necessary for the recruitment of ubiquitin, p62 and NDP52 to the bacteria^[@CR54]^, it is possible that IcsB masks the bacteria from septins and prevents their autophagic targeting. Identifying the septin binding partners on bacteria and elucidating their interactions with IcsB will be necessary to fully understand how IcsB blocks septin cage capture.

*Listeria monocytogenes* is another example of a bacterial pathogen that can mask itself to avoid autophagy recognition. During *L. monocytogenes* infection of mouse macrophages, the bacterium is internalized by phagocytosis but damages the phagosomal membrane, by secretion of the pore-forming toxin listeriolysin O (LLO) and other bacterial and host factors, and escapes into the cytosol to replicate^[@CR109]^. Cytosolic bacteria express ActA, a cell surface protein that recruits the host ARP2/3 (actin-related protein 2/3) complex, which can then polymerize actin on the bacterial surface. The forces that are associated with actin polymerization promote bacterial intracellular motility and cell-to-cell spread^[@CR110]^, which are thought to help the bacteria to escape autophagosome capture^[@CR111],[@CR112]^. Notably, Δ*actA* mutant bacteria are sequestered in LC3-positive, double-membrane vacuoles following the addition of the antibiotic chloramphenicol to block bacterial protein synthesis^[@CR111],[@CR113]^. By contrast, wild-type bacteria are not targeted for autophagy even when treated with chloramphenicol, which suggests that when bacteria have acquired actin on their cell surface they become capable of escaping autophagy at later times during the infection. However, another study using a different *L. monocytogenes* strain found that it was not the actin-based motility but instead the ability of ActA to recruit host proteins (such as actin, the ARP2/3 complex and vasodilator-stimulated phosphoprotein) that enabled the bacteria to escape autophagy^[@CR8]^. Specifically, at 2 hours and 4 hours post-infection, only ∼5% of wild-type bacteria were LC3-positive (and thus targeted for autophagy), but nearly 60% of Δ*actA2* bacteria were associated with LC3 (Ref. [@CR8]). However, *actA*-mutant bacteria, which cannot polymerize actin and lack motility but can recruit other host proteins, successfully escaped autophagy recognition. This suggests that *L. monocytogenes* uses ActA to recruit host cytoskeleton proteins on the bacterial surface and mask the bacterium from ubiquitin recognition and autophagy targeting.

The recently identified *L. monocytogenes* virulence factor internalin K (InlK) also has a role in autophagy escape by interacting with mammalian host major vault protein (MVP) and recruiting it to the bacterial surface^[@CR7]^. MVP and actin are distributed to opposite sides of the bacterial surface and each shields one part of the bacterium to avoid ubiquitin--p62--LC3-mediated autophagy recognition.

***Escaping autophagy by as yet unclear mechanisms.*** Some bacteria use their effector proteins to escape autophagy by mechanisms that remain unclear in terms of the target of the effectors or the exact stage of autophagy that they interfere with. One such example is the Gram-negative bacterium *B. pseudomallei*, which uses a T3SS to escape from the phagosome into the cytosol, where it obtains actin-based motility, replicates and disseminates. Studies have shown that a very small population (∼5--10%) of wild-type *B. pseudomallei* is targeted for LAP^[@CR72]^. Mutants that lack the T3SS3 effector BopA or the translocator BipD are defective in phagosomal escape and exhibit higher levels of colocalization with LC3 (∼30--40%) and LAMP1, indicating that wild-type bacteria use T3SS3 to avoid autophagy recognition. However, most wild-type bacteria enter the cytosol but are not targeted by autophagy. In this case, evasion of autophagy is mediated by T3SS1, as bacteria that lack the putative T3SS1 ATPase encoded by *bpscN* successfully enter the cytosol but are more efficiently targeted by LC3 and show defective survival in RAW macrophages^[@CR114],[@CR115]^.

*M. tuberculosis* str. Erdman has been shown to be targeted and eliminated by autophagy in mouse macrophages (∼30% of bacteria were LC3-positive at 4 hours post-infection)^[@CR116]^. Another study showed that only ∼10% of wild-type bacteria were targeted for autophagy^[@CR117]^. Interestingly, treatment with small interfering RNA against [coronin](#Glos14){ref-type="list"} 1a, which is a protein that associates with filamentous actin, increased the percentage of LC3-positive bacteria to ∼30%, and bacterium-containing phagosomes were captured in autophagosomes via ubiquitin--p62--LC3 recruitment. Thus, in this case, the bacteria interfered with coronin 1a to avoid autophagy targeting. However, the mechanisms by which *M. tuberculosis* can modulate coronin 1a to inhibit autophagy remain unclear.

***Blocking autophagosome fusion with the lysosome.*** Another group of bacteria are recognized by autophagy and are sequestered in autophagosomes but can block or delay the maturation of bacterium-containing autophagosomes into degradative autolysosomes, thus avoiding autophagic killing. The mechanisms by which these bacteria block autophagosome fusion with the lysosome remain mostly unknown. For example, infection with adherent-invasive *Escherichia coli* (AIEC) triggers the accumulation of autophagosomes in the cytosol as well as the sequestration of intracellular bacteria into canonical autophagosomes^[@CR118]^. However, although the AIEC-containing autophagosomes acquire LAMP1, they do not fully mature into degradative autolysosomes, so the bacteria avoid killing. Notably, the upregulation of autophagy by starvation or rapamycin treatment can restrict AIEC growth, suggesting that autophagy is an immune defence mechanism against AIEC^[@CR118]^.

Early after *Mycobacterium marinum* infection of macrophages, LC3 is recruited to a population of *M. marinum*-containing phagosomes^[@CR119]^. These LC3-positive compartments have a single membrane and are decorated with the late endosomal proteins RAB7 and LAMP1, but they do not acquire the lysosomal hydrolase cathepsin D and are not degradative, indicating a block of the LC3-associated phagosome fusion with the lysosome.

Other bacteria, such as *M. tuberculosis* str. H37Rv^[@CR120]^, *Chlamydia trachomatis*^[@CR121],[@CR122]^, *Yersinia pestis*^[@CR123]^ and *Helicobacter pylori*^[@CR124],[@CR125]^, have also been shown to accumulate in non-acidic or non-degradative autophagosomes during infection, but less is known about how these bacteria block autophagosome fusion with the lysosome.

***Hijacking autophagy for growth.*** Some bacteria even actively use autophagy for intracellular growth and infection, and show defective replication in autophagy-deficient cells. These bacteria include *Staphylococcus aureus*^[@CR13]^, *Anaplasma phagocytophilum*^[@CR12],[@CR126]^, *Coxiella burnetii*^[@CR127],[@CR128],[@CR129],[@CR130]^, *Brucella abortus*^[@CR131]^, *Serratia marcescens*^[@CR132]^, *M. tuberculosis* (str. Erdman in epithelial cells)^[@CR133]^, *L. pneumophila* (in permissive A/J mice)^[@CR102],[@CR134]^, *Brucella melitensis*^[@CR135]^, *Porphyromonas gingivalis*^[@CR136]^, uropathogenic *E . coli*^[@CR137]^ and *Yersinia pseudotuberculosis*^[@CR138]^. In most cases, these bacteria actively induce autophagy but at the same time block autophagosome fusion with the lysosome, then use the autophagosome as a replicative niche for their growth.

A well-studied example of a bacterium that uses autophagy components for the biogenesis of its replication compartment is *S. aureus*. The bacteria become sequestered in double-membrane autophagosomes during infection of HeLa cells, but fusion of these autophagosome with the lysosome is inhibited and they are used as replicative niches^[@CR13]^. Following replication, the bacteria escape into the cytosol and cause autophagy-dependent cell death, and this depends on host ATG5 (Ref. [@CR13]) (but not on PtdIns3KC3 and BECN1 (Ref. [@CR139])) and the bacterial accessory gene regulator (Agr) system, specifically the Agr-secreted α-haemolysin (Hla). Indeed, *agr* and *hla* mutants cannot trigger autophagy and are delivered to lysosomes, where they are degraded^[@CR13],[@CR139]^. Interestingly, *S. aureus* infection decreased cellular cAMP levels and reduced the activity of the cAMP effector exchange protein directly activated by cAMP 1 (EPAC; also known as RAPGEF3) and the downstream factor RAP2B^[@CR140]^, suggesting that bacteria trigger autophagy by inhibiting the cellular cAMP--EPAC--RAP2B pathway. Notably, RAP2B is known to increase the levels of cytoplasmic calcium, which is required for the activation of calpains, a family of cysteine proteases that cleave ATG5 to generate a form of ATG5 that does not function in autophagy but instead is involved in apoptosis induction. Similarly, *A. phagocytophilum* grows in double-membrane vacuoles that are decorated with autophagy proteins, such as LC3 and BECN1 (Refs [@CR12], [@CR126]). Autophagosome formation is nucleated by the bacterial T4SS secreted effector anaplasma translocated substrate 1, which directly binds BECN1 (Ref. [@CR126]). However, the autophagosomes do not acquire the late endosomal and lysosomal protein LAMP3, indicating that fusion with the lysosome is impaired. How bacteria block autophagosome maturation is unclear.

Another example of a bacterium that hijacks autophagy is *C. burnetii*, which is the causative agent of Q fever. *C. burnetii* survives after invasion of host cells in large *Coxiella*-replicative vacuoles (CRVs) that are decorated with the autophagy components LC3, BECN1 and RAB24 (Refs [@CR127], [@CR128], [@CR129], [@CR130]). Overexpressing LC3 or BECN1 promotes bacterial infection and increases the number and size of the CRVs at early infection times, and inhibition of autophagy impairs CRV formation and bacterial replication^[@CR127],[@CR130]^. *C. burnetii* infection also induces recruitment of the anti-apoptotic protein B cell lymphoma 2 (BCL-2) to the CRV, and the interaction between BECN1 and BCL-2 is important for CRV development and inhibition of apoptosis^[@CR130]^. Therefore, the bacteria use autophagy components for intracellular replication and block apoptosis to promote persistent infection.

In addition to promoting their growth, some bacteria hijack autophagy components to promote their intercellular spreading. *B. abortus* resides in a *Brucella*-containing vacuole (BCV) after internalization by phagocytic or epithelial cells, and traffics from this endocytic compartment to the ER to form the ER-derived BCV (rBCV), which is permissive for bacterial replication. At a later infection stage, rBCVs further convert into double- or multi-membrane autophagic BCVs (aBCVs), and this requires ULK1 and BECN1--ATG14L--PtdIns3KC3 activity but is independent of membrane elongation factors, including ATG12--ATG5--ATG16L1 and LC3--PE^[@CR131]^. At very late time points during infection, heavily infected cells release bacteria and cause re-infection of neighbouring cells, which generates infection foci. Approximately 80% of these infection foci have been shown to have aBCV-containing cells, and formation of infection foci depended on ULK1 or BECN1 expression as well as on aBCV formation^[@CR131]^. Collectively, these results suggest that *B. abortus* hijacks some of the autophagy components to form the aBCV, which enables bacterial cell-to-cell spread. It was speculated that the aBCVs can promote the release of bacteria out of the cell, but further work is needed to clarify the possible mechanisms that are involved.

Conclusion {#Sec5}
==========

Autophagy was first shown to target intracellular pathogenic bacteria for degradation in 2003, when a study reported that Δ*actA*-mutant *L. monocytogenes* was captured in autophagosomes under certain conditions^[@CR113]^. In the following year, wild-type GAS was shown to be sequestered and eliminated by autophagy during infection of host cells^[@CR85]^, which indicates that autophagy is an important host defence mechanism against bacterial pathogens. Since these two seminal studies, there has been a flurry of research on antibacterial autophagy by microbiologists, cell biologists and immunologists. Notably, although bacteria can be targeted by autophagy, increasing evidence suggests that pathogenic bacteria have developed many ways of interfering with the host autophagy machinery. These include the use of virulence factors to camouflage the bacteria or to directly subvert autophagy signalling and/or autophagy proteins, thereby avoiding autophagy targeting. Bacterial factors can mimic modifiers of autophagy components to shut down their proper functions or directly bind and recruit autophagy proteins to the bacteria to favour their growth.

Many key questions in the field remain to be answered. First, the mechanisms of the signalling induction pathways that trigger xenophagy are largely unknown. So far, *S*. Typhimurium-induced autophagy is the best-studied model, and multiple pathways have been found to contribute to xenophagy. Of note, nucleotide-binding oligomerization domain-containing 1 (NOD1) and NOD2, which are cytosolic NOD-like receptors (NLRs) that detect peptidoglycans on intracellular pathogens, are involved in the induction of autophagy targeting of *S. flexneri* and *L. monocytogenes* by directly binding to ATG16L1 and recruiting it to the bacterial entry site on the plasma membrane^[@CR141]^. It will be important to investigate whether other bacteria that can be sensed by NOD1 and NOD2 also trigger xenophagy by the same mechanism. It will also be necessary to characterize how different signalling pathways regulate xenophagy induction at the same time in a coordinated manner, as well as how they activate autophagy initiation proteins, such as the ULK1 complex.

The mechanisms of selective cargo recognition are not fully understood. Although the ubiquitin--adaptors--LC3 pathway seems to be the main mechanism of autophagy recognition for some bacteria, other mechanisms also exist. For example, tectonin β-propeller repeat-containing protein 1 (TECPR1) is thought to function as a cargo receptor that links autophagosomes to *S. flexneri*, *S*. Typhimurium and GAS by interacting with ATG5 and WIPI2 (Ref. [@CR142]). However, it remains unknown how TECPR1 recognizes different bacteria. Moreover, TECPR1 only localizes to ubiquitin-negative bacteria^[@CR142]^, suggesting that it mediates a ubiquitin-independent pathway. In addition, a recent study showed that human transmembrane protein 59 interacts with ATG16L1 via a 19-amino-acid-long motif^[@CR143]^, thereby selectively targeting endosomes to autophagy. The same ATG16L1-binding motif was found in other proteins, suggesting that adaptor proteins that engage ATG16L1 could target other specific cargoes, such as bacteria, to autophagy.

How certain bacteria block autophagosome fusion with lysosomes, and whether bacterial effectors are involved, remains to be fully elucidated. It is possible that bacteria use their virulence factors to inhibit the recruitment of key factors that are involved in autophagosome--lysosome fusion, such as RAB7, to the bacterium-containing autophagosomes. Searching for bacterial mutants that do not block autophagosome fusion with lysosomes might provide some answers.

Finally, it is unknown, in most cases, whether all components of the canonical autophagy machinery are involved in xenophagy and whether they function in their canonical manner. As discussed above, some bacteria are targeted by LAP, which does not require the ULK1 complex, suggesting that different initiation mechanisms, which possibly do not require mTORC1, might be involved. *S. aureus* induces xenophagy independently of the BECN1 complex^[@CR140]^, and it is unclear whether PtdIns3KC3-independent sources of PtdIns3P are involved in inducing xenophagy or whether PtdIns3P is dispensable in this context.

Investigating the interactions between bacterial factors and ATG proteins has been a major focus of recent research, and it will remain one for many years to come. A better understanding of the mechanisms by which bacteria manipulate autophagy will inform drug design and the therapeutic treatment of bacterial infections.
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Cytoplasm-to-vacuole targeting pathway

:   (Cvt pathway). A constitutive biosynthetic pathway that occurs under nutrient-rich conditions and that delivers precursor aminopeptidase I into the vacuole for maturation.

*Trans*-Golgi network

:   (TGN). A network of tubular and vesicular structures at the *trans* face (that is, the side responsible for export) of the Golgi apparatus.

E1-like enzyme

:   A protein enzyme that, like a ubiquitin-activating enzyme (E1) in the ubiquitylation reaction, catalyses the first step in the covalent conjugation of a ubiquitin-like molecule to the target protein.

E2-like enzyme

:   A protein enzyme that, like a ubiquitin-conjugating enzyme (E2) in the ubiquitylation reaction, catalyses the second step in covalent conjugation of a ubiquitin-like molecule to the target protein.

SNARE proteins

:   (Soluble *N*-ethylmaleimide-sensitive factor attachment protein receptor proteins). A family of membrane proteins that mediate membrane fusion during vesicle fusion and exocytosis. Vesicle-membrane SNAREs (v-SNAREs) localize on the membranes of transporting vesicles, whereas target-membrane SNAREs (t-SNAREs) localize on the target membrane.

E3-like enzyme

:   An enzyme that functions similarly to the ubiquitin ligase (E3), which transfers the ubiquitin from E2 to the substrate by catalysing the covalent attachment of ubiquitin to a lysine residue in the substrate.

Guanine nucleotide exchange factor

:   (GEF). Proteins that bind to small GTPases and catalyse the release of a GDP molecule from, and then the binding of a GTP molecule to, the GTPase substrate to activate the GTPase.

Toll-like receptor

:   (TLR). A protein that belongs to a family of transmembrane protein receptors, usually found in immune cells. It recognizes specific microorganisms and induces immune responses.

Dendritic cells

:   Immune cells that process and present antigens on their surfaces.

Fc receptor

:   An immune cell surface protein receptor that recognizes the Fc region of antibodies and activates phagocytosis of antibody-tagged microorganisms.

Reactive oxygen species

:   (ROS). Oxygen free radicals that harbour unpaired electrons and are highly unstable and reactive.

Type I interferons

:   (Type I IFNs). A group of cytokines that have antiviral functions. In humans, this group consists of IFNα, IFNβ and IFNω. Type I IFNs all bind to the IFNα receptor.

STING

:   (Stimulator of interferon genes). An endoplasmic reticulum-resident transmembrane protein that is involved in the initiation of type I interferon production by cytosolic double-stranded DNA in cells.

Coronin

:   A eukaryotic actin-binding protein that is involved in many actin-mediated cellular processes, such as phagocytosis.
